Hi-C studies across both TMPRSS2–ERG fusion-negative and fusion-positive prostate cancer cell lines reported increased contact frequency in the region between TMPRSS2 and ERG compared to benign prostate cell lines55. This evidence concerns the gene TMPRSS2 and prostate cancer.